Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis

Trial Profile

Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis

Phase of Trial: Phase II/III

Latest Information Update: 06 Oct 2018

At a glance

  • Drugs Rivaroxaban (Primary) ; Warfarin
  • Indications Thromboembolism
  • Focus Therapeutic Use
  • Acronyms RIWAMP
  • Most Recent Events

    • 06 Oct 2018 Trial design published in the Drugs in R and D.
    • 29 Jun 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top